{"disease":{"id":"staphylococcus-s-aureus-infection","name":"staphylococcus s aureus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06719219","title":"A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"LimmaTech Biologics AG","has_results":false},{"nct_id":"NCT04781569","title":"Staphylococcus Aureus Caught in Action at the Site of Infection","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03446053","title":"A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Intron Biotechnology, Inc.","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}